Is this the epitaph for multiple-dose activated charcoal?

The Lancet

Volumn 371, Issue 9612, 2008, Pages 538-539

  Eyer, Peter ^a   Eyer, Florian ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ATROPINE; CARBAMAZEPINE; CARDENOLIDE DERIVATIVE; CARDIAC GLYCOSIDE; CHOLINESTERASE INHIBITOR; FENTHION; PARACETAMOL; PARAQUAT; PESTICIDE; PLANT GLYCOSIDE;

ARTICLE; HUMAN; INTOXICATION; NONHUMAN; PRIORITY JOURNAL; RURAL AREA; SINGLE DRUG DOSE; SOUTH ASIA; THEVETIA;

EID: 38949147386     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60248-2     Document Type: Note

References (13)

1. Eddleston M., Juszczak E., Buckley N., and for the Ox-Col Poisoning Study collaborators. Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial. Lancet 371 (2008) 579-587
2. de Silva H., Fonseka M., Pathmeswaran A., et al. Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. Lancet 361 (2003) 1935-1938
3. Eddleston M., Eyer P., Worek F., et al. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 366 (2005) 1452-1459
4. Bismuth C., Wong A., and Hall A. Paraquat ingestion exposure: symptomatology and risk. In: Bismuth C., and Hall A. (Eds). Paraquat poisoning: mechanisms-prevention-treatment (2005), Marcel Dekker, New York 195-205
5. Krenzelok E., Vale J., and Barceloux D. Multiple-dose activated charcoal. In: Donnovan J. (Ed). Critical care toxicology (2005), Elsevier Mosby, Philadelphia 61-64
6. Tomimaru A., Arimori K., Inotsume N., and Nakano M. Effect of activated charcoal and atropine on absorption and/or exsorption of organophosphorus compounds in rats. J Pharm Pharmacol 48 (1996) 351-356
7. Eyer F., Jung N., Neuberger H., et al. Enteral exsorption of acetaminophen after intravenous injection in rats: influence of activated charcoal on this clearance path. Basic Clin Pharmacol Toxicol 101 (2007) 163-171
8. Eyer F., Jung N., Neuberger H., et al. Seromucosal transport of intravenously administered carbamazepine is not enhanced by oral doses of activated charcoal in rats. Basic Clin Pharmacol Toxicol (2008). published online Jan 30. DOI:10.1111/j.1742-7843.2007.00193.x
9. Roberts D., Southcott E., Potter J., Roberts M., Eddleston M., and Buckley N. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal. Ther Drug Monit 28 (2006) 784-792
10. American Academy of Clinical Toxicology and European Association of Poisons Centres and Clincal Toxicologists. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol 37 (1999) 731-751
11. Bailey D., and Briggs J. The effect of ethanol and pH on the adsorption of drugs from simulated gastric fluid onto activated charcoal. Ther Drug Monit 25 (2003) 310-313
12. Wigton A., and Kilduff J. Modeling trichloroethylene adsorption by activated carbon preloaded with natural dissolved organic matter using a modified IAST approach. Environ Sci Technol 38 (2004) 5825-5833
13. Malhas A., Abuknesha R., and Price R. Removal of detergents from protein extracts using activated charcoal prior to immunological analysis. J Immunol Methods 264 (2002) 37-43